TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biopart AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
28
|
23
|
51 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-17
|
-28
|
5 |
| EBITDA |
-18
|
-29
|
5 |
| Total assets |
70
|
99
|
153 |
| Current assets |
70
|
99
|
153 |
| Current liabilities |
27
|
37
|
8 |
| Equity capital |
43
|
62
|
140 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
61.4%
|
62.6%
|
91.5% |
| Turnover per employee |
28
|
23
|
51 |
| Profit as a percentage of turnover |
-60.7%
|
-121.7%
|
9.8% |
| Return on assets (ROA) |
-24.3%
|
-28.3%
|
3.3% |
| Current ratio |
259.3%
|
267.6%
|
1912.5% |
| Return on equity (ROE) |
-39.5%
|
-45.2%
|
3.6% |
| Change turnover |
5
|
-28
|
-266 |
| Change turnover % |
24%
|
-55%
|
-84% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.